FDA panel to evaluate psychedelic MDMA for treatment of PTSD for first time

The U.S. Food and Drug Administration held a meeting to discuss a therapy based on the psychedelic drug MDMA for patients with post-traumatic stress disorder for the first time.The U.S. Food and Drug Administration held a meeting to discuss a therapy based on the psychedelic drug MDMA for patients with post-traumatic stress disorder for the first time.Read Mored815ddcd-1852-56b8-ac75-f6f828f19ca1, fox-news/us/crime/drugs, fox-news/topic/reuters, fox-news/health/mental-health, fox-news/health/mental-health/ptsd, fox-news/us/military/veterans, fnc, fox-news/health, article, ReutersFOX News : Health